Related Experiment Video
Updated: Jul 26, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
DICER1 platform domain missense variants inhibit miRNA biogenesis and lead to tumor susceptibility
Dylan Pelletier1,2,3, Anne-Laure Chong1,2, Mona Wu1,2
1Department of Human Genetics, Medicine, McGill University, Montreal, QC, Canada.
Abstract:
The endoribonuclease DICER1 plays an essential role in the microRNA (miRNA) biogenesis pathway, cleaving precursor miRNA (pre-miRNA) stem-loops to generate mature single-stranded miRNAs. Germline pathogenic variants (GPVs) in DICER1 result in DICER1 tumor predisposition syndrome (DTPS), a mainly childhood-onset tumor susceptibility disorder. Most DTPS-causing GPVs are nonsense or frameshifting, with tumor development requiring a second somatic missense hit that impairs the DICER1 RNase IIIb domain. Interestingly, germline DICER1 missense variants that cluster in the DICER1 Platform domain have been identified in some persons affected by tumors that also associate with DTPS. Here, we demonstrate that four of these Platform domain variants prevent DICER1 from producing mature miRNAs and as a result impair miRNA-mediated gene silencing. Importantly, we show that in contrast to canonical somatic missense variants that alter DICER1 cleavage activity, DICER1 proteins harboring these Platform variants fail to bind to pre-miRNA stem-loops. Taken together, this work sheds light upon a unique subset of GPVs causing DTPS and provides new insights into how alterations in the DICER1 Platform domain can impact miRNA biogenesis.
Insights
Germline DICER1 variants in the Platform domain prevent mature miRNA production, impairing gene silencing and causing DICER1 tumor predisposition syndrome (DTPS). This contrasts with other variants affecting cleavage, highlighting a unique mechanism of disease.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- DICER1 is crucial for microRNA (miRNA) biogenesis, processing precursor miRNAs (pre-miRNAs) into mature miRNAs.
- Germline pathogenic variants (GPVs) in DICER1 cause DICER1 tumor predisposition syndrome (DTPS), a childhood cancer susceptibility disorder.
- Canonical DTPS arises from nonsense/frameshift DICER1 variants requiring a second somatic hit affecting the RNase IIIb domain.
Purpose of the Study:
- To investigate the impact of germline DICER1 missense variants in the Platform domain on miRNA biogenesis and gene silencing.
- To elucidate the mechanism by which these Platform domain variants contribute to DTPS.
Main Methods:
- Functional assays were used to assess the production of mature miRNAs by DICER1 proteins with Platform domain variants.
- Experiments were conducted to evaluate miRNA-mediated gene silencing.
- Binding assays were performed to determine if Platform variants affect pre-miRNA binding.
Main Results:
- Four Platform domain variants were found to abolish mature miRNA production.
- These variants consequently impaired miRNA-mediated gene silencing.
- Unlike variants affecting cleavage, Platform variants prevent DICER1 from binding to pre-miRNA stem-loops.
Conclusions:
- Germline DICER1 Platform domain variants represent a unique class of GPVs causing DTPS.
- These variants disrupt miRNA biogenesis by preventing substrate binding, rather than altering cleavage activity.
- This study provides novel insights into the molecular mechanisms underlying DICER1-related tumor predisposition.
Related Concept Videos
MicroRNAs
Experimental RNAi
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
piRNA - Piwi-interacting RNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Abnormal Proliferation

